How Much Did Elixir Medical Raise?
Funding & Key Investors

Elixir Medical has established a significant footprint in the cardiovascular technology sector, underscored by a total capital accumulation of $5.3M. This trajectory was bolstered by a major strategic investment of $5.3M, which served as a foundational pillar for the company's long-term research and development initiatives in vascular medicine. By securing this financing, the firm has positioned itself to accelerate the deployment of its proprietary bioadaptor platforms, marking a critical juncture in its corporate evolution.

What is Elixir Medical?

Elixir Medical
ManufacturingMedical Devices & Equipment

Elixir Medical operates at the intersection of medical device engineering and clinical cardiology, focusing on the development of disruptive technologies for coronary and peripheral artery diseases. The company's core value proposition lies in its ability to move beyond traditional stenting, offering advanced solutions like the DynamX Coronary Bioadaptor System. By prioritizing patient-centric outcomes and long-term vascular health, Elixir Medical addresses the global burden of cardiovascular disease, providing healthcare providers with sophisticated tools designed to improve procedural efficacy and patient quality of life. Their portfolio, which includes both investigational devices and CE-marked systems, reflects a commitment to rigorous clinical validation and technological innovation in a highly regulated market.

How much funding has Elixir Medical raised?

Elixir Medical has raised a total of $5.3M across 1 funding round:

2005

Series A

$5.3M

Series A (2005): $5.3M with participation from Invus

Key Investors in Elixir Medical

Invus

Invus Group is an investment firm specializing in financial advice, investment services, and consulting services. The company was founded in 1985 and is headquartered in New York City, New York.

What's next for Elixir Medical?

With the capital secured through its strategic financing rounds, Elixir Medical is poised to scale its commercial operations and expand its clinical trial footprint. The focus remains on the global adoption of the DynamX platform, which represents a paradigm shift in how clinicians approach coronary interventions. Future growth will likely be driven by continued investment in regulatory approvals across international markets and the expansion of its intellectual property portfolio. As the company transitions into a more mature phase of its lifecycle, the emphasis will shift toward optimizing supply chain logistics and deepening partnerships with major hospital networks to ensure the widespread integration of its bioadaptor technology into standard clinical practice.

See full Elixir Medical company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ElectronicsManufacturing
ManufacturingMedical Devices & EquipmentDrug Stores & PharmaciesRetail
Industrial Machinery & EquipmentManufacturing
Food & BeverageManufacturing

Frequently Asked Questions Regarding Elixir Medical Financial Insights

What are the most recent funding rounds that Elixir Medical has completed, and what were the funding rounds?
Elixir Medical has recently completed 1 funding rounds: Series A on Mar 17, 2005.
What is the total amount of funding Elixir Medical has raised to date?
Elixir Medical has raised a total of $5.3M in funding to date.
How many funding rounds has Elixir Medical completed?
Elixir Medical has completed 1 funding rounds.
How much funding did Elixir Medical raise in its most recent funding round?
Elixir Medical raised $5.3M in its most recent funding round.
Who are the lead investors in Elixir Medical's latest funding round?
The lead investor in Elixir Medical's latest funding round was Invus. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Elixir Medical's history?
The largest funding round in Elixir Medical's history was $5.3M.
See more information about Elixir Medical